Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxinesGIESELER, F; GLASMACHER, A; KÄMPFE, D et al.Leukemia. 1996, Vol 10, Num 7, pp 1177-1180, issn 0887-6924Article

Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxinesGIESELER, F; GLASMACHER, A; KÄMPFE, D et al.Leukemia. 1996, Vol 10, pp S46-S49, issn 0887-6924, SUP3Conference Paper

Induction of apoptosis by idarubicin: how important is the plasma peak?GIESELER, F; CLARK, M; STIEBELING, K et al.International journal of clinical pharmacology and therapeutics. 2000, Vol 38, Num 4, pp 217-221, issn 0946-1965Article

Molecular effects of topoisomerase II inhibitors in AML cell lines : correlation of apoptosis with topoisomerase II activity but not with DNA damage : Apoptosis and Chemotherapy ResistanceGIESELER, F; BAUER, E; NUESSLER, V et al.Leukemia. 1999, Vol 13, Num 11, pp 1859-1863, issn 0887-6924Conference Paper

Intracellular pharmacokinetics of anthracyclines in human leukemia cells : correlation of DNA-binding with apoptotic cell deathGIESELER, F; NÜSSLER, V; BRIEDEN, T et al.International journal of clinical pharmacology and therapeutics. 1998, Vol 36, Num 1, pp 25-28, issn 0946-1965Conference Paper